Shady Grove Fertility Philadelphia (Wayne, PA)

Address: 945 Chesterbrook Blvd, Chesterbrook, PA 19087 (Wayne/Chesterbrook) | Phone: (610) 981-6000 | shadygrovefertility.com

Shady Grove Fertility is the largest fertility practice in the United States by most measures — roughly 50 locations spanning the mid-Atlantic, Southeast, Southwest, and beyond. The Chesterbrook location, situated on Chesterbrook Boulevard in Wayne, anchors SGF's Philadelphia-area presence along the Main Line corridor. For patients in Delaware County, Chester County, Montgomery County, and the greater Philadelphia suburbs, this is the primary full-service SGF site serving the region, with a dedicated on-site IVF laboratory and the full complement of the network's clinical programs.

The practice has operated under various names in this geography since the early 2000s — the former Shady Grove Fertility RSC of Pennsylvania was among the earliest SGF affiliates outside Maryland. Today's Chesterbrook center reflects more than two decades of institutional investment in Philadelphia-area reproductive medicine, with an embryology laboratory certified by both the College of American Pathologists (CAP) and SGF's own internal quality program. The location is convenient to King of Prussia, Berwyn, Malvern, Devon, Radnor, and the broader Main Line; Philadelphia city patients typically reach it in 25 to 35 minutes via US-30 or I-76.

Physicians and Clinical Team

The Chesterbrook team includes multiple reproductive endocrinologists with complementary specializations — an important feature for a location handling the diagnostic and treatment complexity that a large metropolitan patient base presents.

Isaac E. Sasson, M.D., Ph.D., FACOG serves as Medical Director for SGF Pennsylvania and sees patients at the Chesterbrook location. Dr. Sasson received his M.D. and doctorate in genetics from Yale School of Medicine, completed his OB/GYN residency at Yale-New Haven Hospital, and then trained in reproductive endocrinology and infertility at the Hospital of the University of Pennsylvania — Penn Medicine's flagship academic center in Philadelphia. His dual background in clinical genetics and reproductive medicine informs his approach to complex cases involving preimplantation genetic testing (PGT), diminished ovarian reserve, and recurrent pregnancy loss. He was named a 2023 Top Doctor for Reproductive Medicine by Main Line Today, one of the region's most widely cited physician recognition programs.

Brianna Schumacher, M.D. is board certified in both Obstetrics and Gynecology and Reproductive Endocrinology and Infertility, and sees patients at the Chesterbrook and Newark, Delaware satellite offices. Her clinical focus spans IVF, IUI, egg freezing, donor egg cycles, and male factor infertility evaluation, with particular attention to individualized ovarian stimulation protocols for patients with variable ovarian reserve.

Nicole M. Marchetto, M.D., MPH brings a public health lens to reproductive medicine — an increasingly relevant perspective as access, equity, and patient-reported outcomes draw greater attention in fertility care. Dr. Marchetto earned her M.D. from Drexel University College of Medicine in Philadelphia and her Master of Public Health from the same institution. She completed OB/GYN residency at Mount Sinai St. Luke's – Mount Sinai West in New York and her REI fellowship at Rutgers New Jersey Medical School. She is board certified in OB/GYN and REI.

Russell Hayden, M.D. is a board-certified urologist with a subspecialty in male infertility and microsurgery, who joined SGF in 2021 and sees patients at Chesterbrook and several other Pennsylvania offices including Warrington, Philadelphia, Mechanicsburg, Lancaster, and York. His presence is a genuine differentiator: male-factor infertility accounts for roughly half of all infertile couples, yet is systematically underdiagnosed and undertreated at fertility practices that do not have an on-site reproductive urologist. Having Dr. Hayden embedded in the team means that azoospermia workups, varicocele assessment, surgical sperm retrieval (TESA, TESE, microTESE), and microsurgical reconstruction can be addressed within the same practice rather than requiring coordination with an outside urology group.

Abraham K. Munabi, M.D. is a reproductive endocrinologist who completed his OB/GYN residency at the State University of New York at Buffalo and his REI fellowship through the National Fellowship Program at the National Institutes of Health, Walter Reed Army Medical Center, and the National Naval Medical Center — one of the more unusually rigorous training pedigrees in American reproductive medicine, reflecting the NIH's emphasis on laboratory research alongside clinical training.

As with all large network practices, patients should ask at their initial consultation which physician will oversee their specific protocol, who performs monitoring appointments, and how the team coordinates for egg retrieval and transfer. SGF is transparent about its shared-care model, and its care coordination staff is a material part of the clinical infrastructure.

Services and Treatments

The Chesterbrook location offers the full slate of SGF clinical programs:

• In vitro fertilization (IVF) — conventional and with intracytoplasmic sperm injection (ICSI)
• Intrauterine insemination (IUI) — with or without ovarian stimulation
• Egg freezing (oocyte cryopreservation) — for elective fertility preservation and for oncofertility patients facing chemotherapy or radiation
• Donor egg IVF — through SGF's national and international frozen donor egg bank, one of the largest in the country
• Donor embryo — adoption of surplus cryopreserved embryos from other families
• Frozen embryo transfer (FET) — programmed or natural-cycle protocols
• Preimplantation genetic testing (PGT-A, PGT-M, PGT-SR) — for aneuploidy screening, monogenic disease, and structural rearrangements
• Ovulation induction with timed intercourse — Clomid and letrozole-based protocols
• Male fertility evaluation and treatment — semen analysis, advanced sperm testing, surgical sperm retrieval, varicocele assessment
• LGBTQ+ family building — including reciprocal IVF, same-sex male donor egg and gestational carrier coordination, and single-parent pathways
• Recurrent pregnancy loss evaluation
• Endometriosis and uterine factor assessment
• Second opinion consultations
• Shared Risk 100% Refund Program — multi-cycle IVF package unique to SGF

Laboratory and Success Rates

The Chesterbrook location houses a full-service on-site IVF laboratory, which matters clinically: embryos are not transported, minimizing handling risk and logistical complexity. The lab is CAP-certified and operates under SGF's network-wide quality protocols, which have been refined across more than 100,000 successful cycles since the practice launched in 1991.

SGF Pennsylvania — Chesterbrook reports its outcomes to the Society for Assisted Reproductive Technology (SART) and is listed in the CDC's annual ART Surveillance Report, accessible via the CDC ART data portal. SART data is reported with a two-year lag (2022 data is the most recently available as of early 2026), so clinic-specific statistics require direct review rather than reliance on any summary figure.

Across the SGF network, own-egg IVF live birth rates for patients under 35 have historically tracked in the mid-to-upper 40 percent range per retrieval — at or above national SART averages. The network was an early proponent of elective single embryo transfer (eSET), which reduces multiples risk even where it marginally lowers headline per-transfer success rates. SGF's own published data reports that more than 82 percent of Shared Risk Program participants take home a baby using their own eggs, rising above 85 percent for donor egg participants.

For context on how to evaluate clinic-reported success rates — including why patient mix, diagnostic complexity, and eSET policies affect comparisons — the SART website explicitly cautions against center-to-center comparisons without accounting for these variables.

Patient Experience

The Chesterbrook office serves a high-volume suburban practice, which shapes the patient experience in predictable ways. Access to multiple REIs, an on-site embryology lab, and robust administrative infrastructure are real advantages. The tradeoff is that patients may see different providers across a cycle, and administrative touchpoints — scheduling, insurance verification, nursing communication — carry more weight in a network practice than they do at a small boutique clinic.

Patient reviews consistently highlight the competence and professionalism of the clinical staff as a particular strength. Dr. Sasson's experience in complex cases and his local training pedigree at Penn Medicine are frequently noted by patients navigating difficult diagnoses. The coordination required for male-factor cases is meaningfully simplified by Dr. Hayden's embedded presence.

Common themes in critical reviews center on administrative responsiveness and care coordination — patterns typical of large-network fertility centers rather than clinical quality concerns. Prospective patients benefit from asking at their first appointment how monitoring results are communicated, who handles after-hours and weekend questions, and what the typical timeline from consultation to cycle start looks like at current volume.

SGF's 96% patient referral rate across the network, and its Castle Connolly ranking as the number-one physician practice for reproductive care in 2024, reflect a level of overall patient satisfaction that independent reviews broadly corroborate. For additional Pennsylvania options, see our guide to fertility clinics in Pennsylvania.

Considering At-Home Insemination?

Not every fertility journey begins in a clinic. At-home intracervical insemination (ICI) is a lower-cost, private option that suits patients with no known fertility diagnosis — including single parents by choice, same-sex couples, and people who want to try a few cycles before committing to clinical treatment.

At-home insemination kits like those from MakeAMom come with step-by-step instructions designed for donor or partner sperm. Kits are a one-time purchase that can be reused until conception succeeds, require no clinic visit, and arrive in plain, discreet packaging. Many patients use them as a first step while working toward a fertility consultation — or alongside ovulation tracking while they wait for an appointment slot.

If you have a known fertility diagnosis, have been trying for 12 months without success (six months if you're over 35), or your physician has already recommended IUI or IVF, a board-certified reproductive endocrinologist is the right next step.

Insurance and Financing

Pennsylvania does not have a state IVF insurance mandate. This is a material financial distinction from neighboring Maryland, where large group employer plans are required to cover up to three IVF attempts per live birth. Pennsylvania patients must rely entirely on voluntary employer benefit elections — which vary considerably by employer, industry, and plan design.

Approximately 70 percent of SGF's Pennsylvania patients have some degree of insurance coverage for infertility treatment, and roughly 90 percent have coverage for an initial consultation. SGF financial counselors verify benefits before treatment starts and prepare an individualized out-of-pocket cost estimate. Coverage for IVF specifically is less consistent than coverage for diagnostics and IUI, and self-funded employer plans are not subject to any state mandate regardless of how generous the plan might appear in marketing materials.

For patients without insurance coverage for IVF, SGF offers several financial pathways:

• Shared Risk 100% Refund Program — a flat fee covering up to six IVF cycles including frozen embryo transfers; if the program concludes without a live birth and you choose to exit, 100% of the deposit is refunded. Eligibility is based on age and ovarian reserve.
• Multi-cycle discount packages — one-cycle, two-cycle, and three-cycle pricing tiers at lower per-cycle cost than paying individually.
• Third-party financing — loans through fertility-specific lenders such as CapexMD and Prosper Healthcare Lending, with financing application available through the practice.
• Fertility grants — SGF's financial counselors can identify grant programs for which a specific patient may qualify.

Medication costs are excluded from global fee packages and typically run $3,000–$6,000 per retrieval cycle depending on protocol and pharmacy channel. For a broader overview of what IVF costs and how to evaluate your IVF treatment options, see our patient guide.

Frequently Asked Questions

Does Shady Grove Fertility Wayne/Chesterbrook accept insurance?

Yes — SGF Chesterbrook accepts most major commercial insurance plans. Because Pennsylvania has no IVF mandate, coverage for IVF specifically depends entirely on your employer's voluntary benefit elections. Approximately 70% of SGF's Pennsylvania patients carry some infertility coverage, and 90% are covered for an initial consultation. SGF financial counselors verify benefits and provide out-of-pocket estimates before treatment begins.

What is the Shared Risk 100% Refund Program?

The Shared Risk program is a prepaid multi-cycle IVF package in which eligible patients pay a flat fee for up to six IVF or donor egg cycles, including frozen embryo transfers. If the program ends without a live birth and you choose to exit the program, 100% of the paid deposit is refunded. Eligibility requires meeting age and ovarian reserve criteria. Medications and diagnostic testing are not included in the flat fee. SGF reports that more than 82% of own-egg Shared Risk participants take home a baby.

Which conditions does the Chesterbrook team specialize in?

The team covers the full range of reproductive medicine, including PCOS, diminished ovarian reserve, endometriosis, recurrent pregnancy loss, unexplained infertility, male-factor infertility (with an on-site reproductive urologist), LGBTQ+ family building, and fertility preservation for oncology patients. Dr. Sasson's background in clinical genetics and PGT is a particular strength for patients with hereditary conditions or prior chromosomally abnormal pregnancies.

How far is the Wayne/Chesterbrook location from Philadelphia?

The Chesterbrook office at 945 Chesterbrook Blvd in Wayne is approximately 18–22 miles west of Center City Philadelphia — typically 25 to 35 minutes by car via I-76 or US-30. It is located within the Chesterbrook Corporate Center, convenient to the King of Prussia Town Center, Berwyn, Malvern, Devon, and Radnor. SGF also operates satellite offices in Philadelphia, Jenkintown/Abington, Warrington, and other Pennsylvania locations for monitoring appointments.